Jason Xiang

1.1k total citations
23 papers, 916 citations indexed

About

Jason Xiang is a scholar working on Organic Chemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jason Xiang has authored 23 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Jason Xiang's work include Hormonal Regulation and Hypertension (8 papers), Catalytic C–H Functionalization Methods (6 papers) and Oxidative Organic Chemistry Reactions (5 papers). Jason Xiang is often cited by papers focused on Hormonal Regulation and Hypertension (8 papers), Catalytic C–H Functionalization Methods (6 papers) and Oxidative Organic Chemistry Reactions (5 papers). Jason Xiang collaborates with scholars based in United States, Canada and United Kingdom. Jason Xiang's co-authors include P. L. Fuchs, Wanlong Jiang, Manus Ipek, James F. Tobin, Vipin Suri, Yuzhe Xing, Steve Tam, May Tam, Tarek S. Mansour and John C. McKew and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Jason Xiang

23 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Xiang United States 18 621 171 110 91 81 23 916
Frederick W. Goldberg United Kingdom 15 418 0.7× 320 1.9× 78 0.7× 44 0.5× 53 0.7× 35 807
Gee‐Hong Kuo United States 22 540 0.9× 486 2.8× 134 1.2× 30 0.3× 43 0.5× 46 1.0k
Jeremy J. Edmunds United States 20 631 1.0× 427 2.5× 45 0.4× 64 0.7× 23 0.3× 54 1.1k
William McCoull United Kingdom 15 1.0k 1.6× 328 1.9× 65 0.6× 61 0.7× 34 0.4× 29 1.2k
Leonard L. Winneroski United States 14 399 0.6× 492 2.9× 38 0.3× 44 0.5× 42 0.5× 22 901
David J. St. Jean United States 16 425 0.7× 258 1.5× 113 1.0× 47 0.5× 13 0.2× 28 751
Dooseop Kim United States 16 689 1.1× 201 1.2× 98 0.9× 63 0.7× 29 0.4× 21 1.1k
Martin S. Domalski United States 13 340 0.5× 189 1.1× 40 0.4× 29 0.3× 62 0.8× 22 571
Daniel Kuzmich United States 12 287 0.5× 111 0.6× 53 0.5× 74 0.8× 13 0.2× 23 527
Thomas J. Rayl United States 9 411 0.7× 230 1.3× 47 0.4× 35 0.4× 23 0.3× 10 692

Countries citing papers authored by Jason Xiang

Since Specialization
Citations

This map shows the geographic impact of Jason Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Xiang more than expected).

Fields of papers citing papers by Jason Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Xiang. The network helps show where Jason Xiang may publish in the future.

Co-authorship network of co-authors of Jason Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Xiang. A scholar is included among the top collaborators of Jason Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Xiang. Jason Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Rui, Lei Wu, Bing Zhang, et al.. (2023). Abstract 4492: A novel and potent FLT3 and IRAK4 dual inhibitor for the treatment of acute myeloid leukemia. Cancer Research. 83(7_Supplement). 4492–4492. 1 indexed citations
2.
Wan, Zhao‐Kui, Huan‐Qiu Li, Manus Ipek, et al.. (2012). Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 4(1). 118–123. 11 indexed citations
3.
4.
Hu, Yonghan, Lei Xing, Jennifer R. Thomason, et al.. (2011). Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition. Bioorganic & Medicinal Chemistry Letters. 21(22). 6800–6803. 4 indexed citations
5.
Hopper, Darrin W., Matthew D. Vera, Jason Xiang, et al.. (2009). Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: A class of potent aggrecanase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(9). 2487–2491. 20 indexed citations
6.
Kirincich, Steven J., Jason Xiang, Neal Green, et al.. (2009). Benzhydrylquinazolinediones: Novel cytosolic phospholipase A2α inhibitors with improved physicochemical properties. Bioorganic & Medicinal Chemistry. 17(13). 4383–4405. 24 indexed citations
7.
Xiang, Jason, Zhao‐Kui Wan, Huan‐Qiu Li, et al.. (2008). Piperazine Sulfonamides as Potent, Selective, and Orally Available 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors with Efficacy in the Rat Cortisone-Induced Hyperinsulinemia Model. Journal of Medicinal Chemistry. 51(14). 4068–4071. 26 indexed citations
8.
Xiang, Jason, Manus Ipek, Vipin Suri, et al.. (2007). β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action. Bioorganic & Medicinal Chemistry. 15(13). 4396–4405. 98 indexed citations
9.
Xiang, Jason, Manus Ipek, Vipin Suri, et al.. (2005). Synthesis and biological evaluation of sulfonamidooxazoles and β-keto sulfones: selective inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 15(11). 2865–2869. 72 indexed citations
10.
Xiang, Jason, Yonghan Hu, Thomas S. Rush, et al.. (2005). Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 311–316. 28 indexed citations
11.
Li, Jianchang, Thomas S. Rush, Wěi Li, et al.. (2005). Synthesis and SAR of highly selective MMP-13 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(22). 4961–4966. 55 indexed citations
12.
Hu, Yonghan, Jason Xiang, Martin DiGrandi, et al.. (2005). Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry. 13(24). 6629–6644. 90 indexed citations
13.
14.
Xiang, Jason, Jing Chen, Lih-Ren Chen, et al.. (2003). Structure–activity studies of a series of dipyrazolo[3,4-b:3′,4′-d]pyridin-3-ones binding to the immune regulatory protein B7.1. Bioorganic & Medicinal Chemistry. 11(13). 2991–3013. 31 indexed citations
15.
Xiang, Jason & P. L. Fuchs. (1998). Chemospecific alkynylation of organic iodides. Tetrahedron Letters. 39(47). 8597–8600. 39 indexed citations
16.
Xiang, Jason, et al.. (1997). Stereospecific Alkenylation of C−H Bonds via Reaction with β-Heteroatom-Functionalized Trisubstituted Vinyl Triflones1. Journal of the American Chemical Society. 119(18). 4123–4129. 94 indexed citations
17.
Xiang, Jason, Wanlong Jiang, & P. L. Fuchs. (1997). Scope and Limitations of Functionalized Acetylenic Triflones in the Direct Alkynylation of C-H Bonds.. Tetrahedron Letters. 38(38). 6635–6638. 41 indexed citations
18.
Xiang, Jason, Anu Mahadevan, & P. L. Fuchs. (1996). Stereo- and Regiospecific Syntheses of α- and β-Substituted Vinyl and Dienyl Triflones via the Stille Reaction1. Journal of the American Chemical Society. 118(18). 4284–4290. 40 indexed citations
19.
Xiang, Jason & P. L. Fuchs. (1996). Alkenylation of C−H Bonds via Reaction with Vinyl and Dienyl Triflones. Stereospecific Synthesis of Trisubstituted Vinyl Triflones via Organocopper Addition to Acetylenic Triflones1. Journal of the American Chemical Society. 118(47). 11986–11987. 79 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frederick W. Goldberg Breakdown of academic impact, for papers by Gee‐Hong Kuo Breakdown of academic impact, for papers by Jeremy J. Edmunds Breakdown of academic impact, for papers by William McCoull Breakdown of academic impact, for papers by Leonard L. Winneroski Breakdown of academic impact, for papers by David J. St. Jean Breakdown of academic impact, for papers by Dooseop Kim Breakdown of academic impact, for papers by Martin S. Domalski Breakdown of academic impact, for papers by Daniel Kuzmich Breakdown of academic impact, for papers by Thomas J. Rayl
Rankless by CCL
2026